• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

drug manufacturing

India India pharma Indian pharmaceutical industry rupee pills
Biotech

How India can build on its budding innovative R&D moment: report

A string of recent wins on the frontiers of novel drug development could mean that a homegrown innovation industry is within reach.
Fraiser Kansteiner Jul 23, 2026 5:00am
topic report
Makary
Favicon Fierce Pharma

FDA's Makary shares policy requests with Congress

Apr 7, 2026 11:04am
NVS
Favicon Fierce Pharma

Novartis pledges nearly $480M to bolster China production, R&D

Mar 23, 2026 10:35am
2026 year ahead look ahead preview forecast new year
Favicon Fierce Pharma

3 biopharma CEOs explain why they are 'authentically optimistic'

Jan 6, 2026 11:54am
Rise increase upward trajectory arrow ascent ascending
Favicon Fierce Pharma

Teva debuts innovation platform to parry key industry challenges

Nov 19, 2025 8:38am
GSK
Favicon Fierce Pharma

GSK plots $30B investment in US manufacturing, R&D

Sep 16, 2025 7:01pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings